Allmed Solutions Ltd. ALMD
TASE · Israel · Health Technology
ILA 32.40-0.10 (-0.31%)
Market closed· · ILA · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · ILA · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Most Gulf markets have recently retreated due to tensions surrounding stalled U.S.-Iran peace talks, impacting investor sentiment across the region. Despite these challenges, certain investment opportunities remain attractive, particularly for those looking beyond established market leaders. Penny stocks, often viewed as relics of past trading eras, continue to offer potential for growth and affordability when backed by strong financials.
The Middle Eastern stock markets have recently experienced volatility, with Gulf shares slipping due to geopolitical tensions affecting investor sentiment. Despite these challenges, the appeal of penny stocks remains significant for investors looking for growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, can offer a unique blend of value and potential growth when supported by strong financials and sound fundamentals.
TruLeaf Medical, Ltd, a fully-owned subsidiary of Allmed Solutions (TASE: ALMD), a clinical-stage medical device company specializing in transcatheter structural heart innovations, is pleased to announce the successful completion of the full two-stage percutaneous heart valve implantation procedure in two additional high-risk patients suffering from severe, refractory heart failure due to leaky tricuspid valve (TR). The first stage of the docking device implantation was performed 3 months ago. I
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.